Evaluation of the prognostic and predictive value of HER-1/EGFR in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapy.
Tzaida O, Gogas H, Dafni U, Kyroudi A, Papaspyrou I, Kyriakou V, Malamou-Mitsi V, Alamani M, Skopa C, Kostopoulos I, Kastritis E, Pectasides D, Briasoulis E, Kalofonos HP, Aravantinos G, Fountzilas G, Arapantoni-Dadioti P.
Tzaida O, et al. Among authors: kyroudi a.
Oncology. 2007;72(5-6):388-96. doi: 10.1159/000113148. Epub 2008 Jan 14.
Oncology. 2007.
PMID: 18187961
Clinical Trial.